StockNews.com began coverage on shares of NanoString Technologies (NASDAQ:NSTG – Free Report) in a report released on Friday morning. The brokerage issued a sell rating on the biotechnology company’s stock. NSTG has been the subject of a number of other research reports. Morgan Stanley lowered their price target on NanoString Technologies from $14.00 to $8.00 […]